Data as of 11:15am ET
| +0.48 / +0.39%|
The 2 analysts offering 12-month price forecasts for Bio-Rad Laboratories Inc have a median target of 140.50, with a high estimate of 150.00 and a low estimate of 131.00. The median estimate represents a +12.85% increase from the last price of 124.50.
The current consensus among 2 polled investment analysts is to Buy stock in Bio-Rad Laboratories Inc. This rating has held steady since April, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.